Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series. [electronic resource]
Producer: 20200401Description: 4 p. digitalISSN:- 2051-1426
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antineoplastic Agents, Immunological -- adverse effects
- Azetidines -- adverse effects
- Exanthema -- chemically induced
- Female
- Humans
- Immunotherapy -- adverse effects
- MAP Kinase Kinase Kinases -- antagonists & inhibitors
- Male
- Melanoma -- drug therapy
- Middle Aged
- Nivolumab -- adverse effects
- Piperidines -- adverse effects
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Protein Kinase Inhibitors -- adverse effects
- Skin -- drug effects
- Skin Neoplasms -- drug therapy
- Vemurafenib -- adverse effects
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.